Reply to "Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium"
J Allergy Clin Immunol Pract
.
2021 Jun;9(6):2541-2542.
doi: 10.1016/j.jaip.2021.03.031.
Authors
Mark Ballow
1
,
Christopher L Haga
2
Affiliations
1
Department of Molecular Medicine, Scripps Research Institute, Jupiter, Fla. Electronic address: mballow@usf.edu.
2
Division of Allergy and Immunology, Department of Pediatrics, Morsani College of Medicine, University of South Florida, St Petersburg, Fla.
PMID:
34112485
PMCID:
PMC8181745
DOI:
10.1016/j.jaip.2021.03.031
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Endothelium, Vascular
Humans
SARS-CoV-2